Stephen Liu

Ram Govindan, a clinical investigator from Washington University specializing in non-small cell lung cancer, joins Stephen Liu from Georgetown University, who focuses on innovative immunotherapy treatments. They discuss groundbreaking advancements in combining chemotherapy with immunotherapy, showing improved survival rates. The conversation highlights the potential of bispecific therapies and antibody-drug conjugates, as well as the role of biomarkers in personalizing treatment. They also touch on emerging strategies like TDXD for HER2 mutations, shaping the future of lung cancer therapy.

In this engaging discussion, Dr. Stephen Liu, an international lung cancer expert and Director at Georgetown Lombardi Cancer Center, dives into the intricacies of extensive stage small cell lung cancer. He highlights breakthroughs in therapies from the Empower 133 and Caspian trials, addressing the integration of immunotherapy. The podcast tackles the controversial use of prophylactic cranial radiation and explores innovative treatments like Tarlatamab. Additionally, Dr. Liu shares invaluable career advice for budding oncologists, stressing the importance of mentorship and personal values.

Dr. Stephen Liu, an international lung cancer expert and Director of Thoracic Oncology at Georgetown Lombardi Cancer Center, dives into the complexities of Small Cell Lung Cancer (SCLC). He discusses the impact of smoking and emerging cases among non-smokers. The conversation covers essential staging methods and effective treatment strategies, emphasizing immunotherapy breakthroughs from recent studies. Liu also explores the integration of immunotherapy with chemotherapy and its promising yet gradual outcomes, shedding light on the evolving landscape of lung cancer treatment.